ArticleProceedings of the National Academy of Sciences of the United States of America2023

Imaging tumor lactate is feasible for identifying intermediate-risk prostate cancer patients with postsurgical biochemical recurrence.

Nikita Sushentsev et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.